beta-alanine has been researched along with Demyelinating Diseases in 1 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Importantly, psychosine-induced demyelination was also attenuated by BAF312." | 1.43 | The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures. ( Dev, KK; Mir, AK; O'Sullivan, C; Schubart, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Sullivan, C | 1 |
| Schubart, A | 1 |
| Mir, AK | 1 |
| Dev, KK | 1 |
1 other study available for beta-alanine and Demyelinating Diseases
| Article | Year |
|---|---|
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Astrocytes; Azetidines; Benzyl Compounds; beta- | 2016 |